BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31065273)

  • 1. Acute Leukemia Induces Senescence and Impaired Osteogenic Differentiation in Mesenchymal Stem Cells Endowing Leukemic Cells with Functional Advantages.
    Bonilla X; Vanegas NP; Vernot JP
    Stem Cells Int; 2019; 2019():3864948. PubMed ID: 31065273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukemia-Induced Cellular Senescence and Stemness Alterations in Mesenchymal Stem Cells Are Reversible upon Withdrawal of B-Cell Acute Lymphoblastic Leukemia Cells.
    Vanegas NP; Ruiz-Aparicio PF; Uribe GI; Linares-Ballesteros A; Vernot JP
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic and Functional Alterations of Hematopoietic Stem and Progenitor Cells in an In Vitro Leukemia-Induced Microenvironment.
    Vernot JP; Bonilla X; Rodriguez-Pardo V; Vanegas NP
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28216566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of quiescence and self-renewal capacity of hematopoietic stem cell in an in vitro leukemic niche.
    Vanegas NP; Vernot JP
    Exp Hematol Oncol; 2017; 6():2. PubMed ID: 28078190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of high glucose conditions on the expansion and differentiation capabilities of mesenchymal stromal cells derived from rat endosteal niche.
    Al-Qarakhli AMA; Yusop N; Waddington RJ; Moseley R
    BMC Mol Cell Biol; 2019 Nov; 20(1):51. PubMed ID: 31752674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual Targeting of Stromal Cell Support and Leukemic Cell Growth by a Peptidic PKC Inhibitor Shows Effectiveness against B-ALL.
    Ruiz-Aparicio PF; Vanegas NP; Uribe GI; Ortiz-Montero P; Cadavid-Cortés C; Lagos J; Flechas-Afanador J; Linares-Ballesteros A; Vernot JP
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32466311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Senescence-unrelated impediment of osteogenesis from Flk1+ bone marrow mesenchymal stem cells induced by total body irradiation and its contribution to long-term bone and hematopoietic injury.
    Ma J; Shi M; Li J; Chen B; Wang H; Li B; Hu J; Cao Y; Fang B; Zhao RC
    Haematologica; 2007 Jul; 92(7):889-96. PubMed ID: 17606438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cells show functional defect and decreased anti-cancer effect after exposure to chemotherapeutic drugs.
    Somaiah C; Kumar A; Sharma R; Sharma A; Anand T; Bhattacharyya J; Das D; Deka Talukdar S; Jaganathan BG
    J Biomed Sci; 2018 Jan; 25(1):5. PubMed ID: 29351753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ally to adversary: mesenchymal stem cells and their transformation in leukaemia.
    Sharma M; Ross C; Srivastava S
    Cancer Cell Int; 2019; 19():139. PubMed ID: 31139016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NR2F2 regulates bone marrow-derived mesenchymal stem cell-promoted proliferation of Reh cells.
    Zhu N; Wang H; Wei J; Wang B; Shan W; Lai X; Zhao Y; Yu J; Huang H
    Mol Med Rep; 2016 Aug; 14(2):1351-6. PubMed ID: 27314877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Senescent Mesenchymal Stem Cells Contribute to Progression of Myelodysplastic Syndromes-Review].
    Pang YB; Li WW; Luo JM; Ji J; DU X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Jun; 26(3):942-946. PubMed ID: 29950248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration Analysis of Bone Marrow Mesenchymal Stromal Cells from De Novo Acute Myeloid Leukemia Patients at Diagnosis.
    Desbourdes L; Javary J; Charbonnier T; Ishac N; Bourgeais J; Iltis A; Chomel JC; Turhan A; Guilloton F; Tarte K; Demattei MV; Ducrocq E; Rouleux-Bonnin F; Gyan E; Hérault O; Domenech J
    Stem Cells Dev; 2017 May; 26(10):709-722. PubMed ID: 28394200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of Melanoma Cell Adhesion Molecule (MCAM/CD146) Accelerates Cellular Senescence in Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells.
    Jin HJ; Kwon JH; Kim M; Bae YK; Choi SJ; Oh W; Yang YS; Jeon HB
    Stem Cells Transl Med; 2016 Apr; 5(4):427-39. PubMed ID: 26941359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel therapeutic strategies to target leukemic cells that hijack compartmentalized continuous hematopoietic stem cell niches.
    Hira VVV; Van Noorden CJF; Carraway HE; Maciejewski JP; Molenaar RJ
    Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):183-198. PubMed ID: 28363872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN-γ induces senescence-like characteristics in mouse bone marrow mesenchymal stem cells.
    Yang ZX; Mao GX; Zhang J; Wen XL; Jia BB; Bao YZ; Lv XL; Wang YZ; Wang GF
    Adv Clin Exp Med; 2017; 26(2):201-206. PubMed ID: 28791835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
    Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
    Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vitro and In Vivo Modeling of Normal and Leukemic Bone Marrow Niches: Cellular Senescence Contribution to Leukemia Induction and Progression.
    Salazar-Terreros MJ; Vernot JP
    Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteogenic niche in the regulation of normal hematopoiesis and leukemogenesis.
    Le PM; Andreeff M; Battula VL
    Haematologica; 2018 Dec; 103(12):1945-1955. PubMed ID: 30337364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microscale roughness regulates laminin-5 secretion of bone marrow mesenchymal stem cells.
    Zou J; Wang W; Nie Y; Xu X; Ma N; Lendlein A
    Clin Hemorheol Microcirc; 2019; 73(1):237-247. PubMed ID: 31561334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-Derived Growth Factor-BB Protects Mesenchymal Stem Cells (MSCs) Derived From Immune Thrombocytopenia Patients Against Apoptosis and Senescence and Maintains MSC-Mediated Immunosuppression.
    Zhang JM; Feng FE; Wang QM; Zhu XL; Fu HX; Xu LP; Liu KY; Huang XJ; Zhang XH
    Stem Cells Transl Med; 2016 Dec; 5(12):1631-1643. PubMed ID: 27471307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.